Arresto Biosciences Mergers and Acquisitions Summary

Life Science Company

Arresto Biosciences has acquired 1 company of its own. A total of 1 acquisition came from private equity firms.

Arresto Biosciences’ largest acquisition to date was in 2010, when it acquired Aeon Bioscience for $255M. Arresto Biosciences has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

Join Mergr and gain access to Arresto Biosciences’ M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 1

Arresto Biosciences, Inc.

3183 Porter Drive,
Palo Alto, California 94304
United States,

Arresto Biosciences is a biotechnology company that develops medicines to treat fibrotic diseases and cancer by targeting enzymes involved in the synthesis of the extracellular matrix. In addition to AB0024, the company has preclinical candidates targeting proteins associated with various inflammatory diseases. The company is headquartered in Palo Alto, California.

M&A Summary

Buy vs Sell

Year ≤ '16 '17 '18 '19 '20 '21 T
Buy (0.0/yr) # 1 - - - - - 1
vol $255M $255M
Sell (0.0/yr) # - - - - - - 0

Most Recent M&A

Company Date Value Type
Aeon Bioscience, Inc. 2010-12-20 255M USD Add-on Acquisition
Birmingham, Alabama ·
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (100%) 255M (100%) - -
Total 1 $255M - -

By Geo

State/Country Buy Value Sell Value
United States 1 255M - -
  Alabama 1 255M - -
Total 1 $255M - -

Deal Values

buy # Total
$100M to $1B 1 $255M
Largest Aeon Bioscience, Inc.
$255M (2010-12-20)

M&A Connections

Acquired from
1 (100%)

 Subscribe to unlock this and 165,390
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
  • 4.2K Private Equity Firms
  • 154K M&A Transactions
  • 161K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.3K M&A Advisors
    (Investment Banks and Law Firms)
  • 51K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.